To resolve a spate of whistleblower lawsuits, drug manufacturer Cephalon has agreed to pay $431 million in civil and criminal fines for illegally promoting "off-label" uses for three of its drugs, federal prosecutors said. In a global settlement with the DOJ, Cephalon agreed, in part, to pay $375 million to settle claims by the Medicaid and Medicare trust funds and to plead guilty to a misdemeanor criminal charge of distribution of misbranded drugs and pay $50 million in fines and forfeiture.
September 30, 2008 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Correction: Due to an error in court records, an earlier version of this article misidentified attorney Brian P. Kenney, the lawyer for lead whistleblower Lucia Paccione. Kenney is a partner with Kenney Egan McCafferty & Young in Plymouth Meeting, Pa.
To resolve a spate of whistleblower lawsuits, drug manufacturer Cephalon Inc. of Frazer, Pa., has agreed to pay $431 million in civil and criminal fines for illegally promoting “off-label” uses for three of its drugs, federal prosecutors said.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
